KarMac secures 2026 MGB GCTI Chemistry, Manufacturing & Controls (CMC) Award

The KarMac team has been selected for the 2026 Chemistry, Manufacturing & Controls (CMC) Award from the Massachusetts General Brigham (MGB) Gene and Cell Therapy Institute (GCTI). This award will support the continued development, scaling, and progression of our therapeutic platforms.